METHOD FOR REHABILITATION OF PATIENTS WITH BRONCHOPULMONAL PATHOLOGY OF INFECTIOUS GENESIS Russian patent published in 2021 - IPC A61N1/00 G01N33/00 

FIELD: medicine.

SUBSTANCE: invention relates to medicine and namely to exercise therapy and physiotherapy. It particularly relates to the treatment of patients with bronchopulmonary pathology of infectious genesis and can be used at all stages of medical rehabilitation. Compression is carried out through a system of pneumatic cuff connections with a compression station. The operating modes of the device allow you to select the compression in pneumatic cuffs of 3 levels. Given the reports in the scientific literature about the need for a particularly gentle nature of the effects on the lung tissue of a patient with COVID-19, the chest compression mode and, therefore, the patient's activity increase gradually from the first to subsequent procedures. At the first procedure, the compression is set at the 1st level, at the 2nd procedure at the second level, at the 3rd procedure and subsequent levels, the compression corresponds to the 3rd level. The settings for the operation of the device allow you to change the duration of the compression and decompression phases of the chest. Influence with a low-frequency vibrator begins with 3 procedures. A low-frequency vibrator is installed in the projection of the legs of the diaphragm to the right and left of the spine at the costal arch level. The impact of the vibrator occurs synchronously with the operation of the compression station for pumping air into the system during the cycle of the selected duration. Before performing the procedure, the patient receives instructions for execution - when compressing through the pneumatic cuff, the patient must inhale in the direction of chest compression; when the device is paused, exhalation is performed through the lips closed by the tube. The course consists of 10 procedures.

EFFECT: method provides an increase in the effectiveness of a comprehensive set of rehabilitation measures and allows you to obtain a pronounced and lasting clinical effect in patients with bronchopulmonary pathology including COVID-19 and also increases the functional capabilities of the respiratory muscles with the development of maximum compensatory capabilities by recruiting a larger volume of lung tissue for gas exchange and providing secondary prevention of complications of the bronchopulmonary system.

1 cl, 1 tbl, 2 ex